Science Explorer Interactive view Map
Company · Prague · Czechia

Apigenex (Czechia)

apigenex.comROR OpenAlex
Research works
41
▲ 19% vs 2013–17
Citations
351
8.6 per fractional work
Top-10% rate
13.1%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Apigenex (Czechia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.89× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 9.86× its world share, 1 worksImmunology and Micro…Chemical Engineering: 4.97× its world share, 0 worksChemical EngineeringEngineering: 0.23× its world share, 0 worksEngineeringMedicine: 3.66× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 1.83× its world share, 0 worksEconomics, Econometr…Psychology: 0.19× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.9×. Every wedge is a field page.

Who are the top researchers at Apigenex (Czechia)?

Ranked on the composite score, T. Mlcoch lead among researchers whose main affiliation is Apigenex (Czechia).

  1. 1 T. Mlcoch Czechia · #1,259,240 worldwide 2 citations · 17 works
All ranked researchers at Apigenex (Czechia)

Which keywords describe research at Apigenex (Czechia)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Inflammation, Drug Development Costs, Generic Drugs, Epidemiology and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life5▲ 9.4×6 topics
  2. Epidemiology4▲ 2.8×17 topics
  3. Inflammation4▲ 4.4×18 topics
  4. Cost-effectiveness Analysis4▲ 119×1 topic
  5. Health Utility Measures4▲ 119×1 topic
  6. Drug Development Costs3▲ 267×1 topic
  7. Generic Drugs3▲ 267×1 topic
  8. Monoclonal Antibodies2▲ 40×2 topics
  9. Cancer2▲ 3.4×10 topics
  10. Antioxidant2▲ 5.8×5 topics
  11. Alzheimer's Disease2▲ 13×3 topics
  12. Medicinal Chemistry2▲ 10×7 topics
  13. Metabolic Syndrome2▲ 4.3×6 topics
  14. Cognitive Impairment1▲ 15×3 topics
  15. Drug Discovery1▲ 8.5×5 topics
  16. Obesity1▲ 4.4×4 topics
  17. Diabetes1▲ 6.1×5 topics
  18. Flavonoids1▲ 13×3 topics
  19. Metabolism1▲ 5.1×3 topics
  20. Anticancer Agents1▲ 12×6 topics
  21. Biosimilars1▲ 190×1 topic
  22. Fc Receptors1▲ 29×1 topic
  23. Glycosylation1▲ 14×2 topics
  24. Immunogenicity1▲ 56×1 topic
  25. Pharmacokinetics1▲ 10×2 topics
  26. Therapeutic Antibodies1▲ 23×1 topic
  27. Gene Therapy1▲ 10×2 topics
  28. Global Prevalence1▲ 29×2 topics
  29. IL-171▲ 102×1 topic
  30. Immune System1▲ 8.2×2 topics
  31. Inhibitors1▲ 39×2 topics
  32. TH17 Cells1▲ 102×1 topic
  33. Efficacy1▲ 56×2 topics
  34. Factor VIII1▲ 142×1 topic
  35. Ginkgo Biloba1▲ 274×1 topic
  36. Hemophilia1▲ 142×1 topic
  37. Myopia1▲ 38×1 topic
  38. Neuroprotective1▲ 20×1 topic
  39. Nuclear Receptors1▲ 13×2 topics
  40. Visual Impairment1▲ 53×1 topic

Which research topics does Apigenex (Czechia) publish most on?

By volume in 2022–2025: Ophthalmology and Visual Impairment Studies, Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments and Myasthenia Gravis and Thymoma.

Ophthalmology and Visual…1Ophthalmology and Visual Impairment Studies: 1 fractional worksPsoriasis: Treatment and…1Psoriasis: Treatment and Pathogenesis: 1 fractional worksSpondyloarthritis Studie…0Spondyloarthritis Studies and Treatments: 0 fractional worksMyasthenia Gravis and Thymoma: 0 fractional worksAllergic Rhinitis and Sensitization: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksMultiple Myeloma Research and Treatments: 0 fractional worksPulmonary Hypertension Research and Treatments: 0 fractional worksFood Allergy and Anaphylaxis Research: 0 fractional works
EpidemiologyImmunologyRheumatologyNeurology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ophthalmology and Visual Impairment Studies Epidemiology 1 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  3. 3 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  4. 4 Myasthenia Gravis and Thymoma Neurology 0 works
  5. 5 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  6. 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  7. 7 Dermatology and Skin Diseases Dermatology 0 works
  8. 8 Multiple Myeloma Research and Treatments Hematology 0 works
  9. 9 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
  10. 10 Food Allergy and Anaphylaxis Research Immunology and Allergy 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.3%not open48.7%

World: 28% of research is openly available.

with international co-authors25.8%domestic only74.2%

World: 19% is written across borders.

How has Apigenex (Czechia)'s research output changed?

Output in 2018–2022 was 19% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Prague

All research institutions in Prague

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.